Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Meacci

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Current Rheumatology Reviews|July 2, 2016
A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory ArthritisValentina Grossi, Maria Infantino, Mariangela Manfredi, et al.
Immunologic Research|November 14, 2014
Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritisAlvin Yee, Tyler Webb, Andrea Seaman, et al.
Arthritis Research & Therapy|December 18, 2015
Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseasesMaria Infantino, Francesca Meacci, Valentina Grossi, et al.
Cytometry. Part B, Clinical Cytometry|January 22, 2017
Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead-based FACS CANTO II cytometersValentina Grossi, Maria Infantino, Francesca Meacci, et al.
Immunologic Research|July 25, 2016
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational studyMaurizio Benucci, Francesca Li Gobbi, Francesca Bandinelli, et al.
Biologics : Targets & Therapy|April 5, 2016
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumabMaurizio Benucci, Francesca Meacci, Valentina Grossi, et al.
Tuberculosis (Edinburgh, Scotland)|June 23, 2009
Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern EuropeManuela Pardini, Stefan Niemann, Francis Varaine, et al.
Plos One|September 3, 2011
Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infectionMaryline Bonnet, Manuela Pardini, Francesca Meacci, et al.
Seminars in Arthritis and Rheumatism|November 27, 2015
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Current Rheumatology Reviews|July 2, 2016
A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory ArthritisValentina Grossi, Maria Infantino, Mariangela Manfredi, et al.
Immunologic Research|November 14, 2014
Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritisAlvin Yee, Tyler Webb, Andrea Seaman, et al.
Arthritis Research & Therapy|December 18, 2015
Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseasesMaria Infantino, Francesca Meacci, Valentina Grossi, et al.
Cytometry. Part B, Clinical Cytometry|January 22, 2017
Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead-based FACS CANTO II cytometersValentina Grossi, Maria Infantino, Francesca Meacci, et al.
Immunologic Research|July 25, 2016
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational studyMaurizio Benucci, Francesca Li Gobbi, Francesca Bandinelli, et al.
Biologics : Targets & Therapy|April 5, 2016
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumabMaurizio Benucci, Francesca Meacci, Valentina Grossi, et al.
Tuberculosis (Edinburgh, Scotland)|June 23, 2009
Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern EuropeManuela Pardini, Stefan Niemann, Francis Varaine, et al.
Plos One|September 3, 2011
Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infectionMaryline Bonnet, Manuela Pardini, Francesca Meacci, et al.
Seminars in Arthritis and Rheumatism|November 27, 2015
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Pageof 4